| May 17, 2026 | Blue Shield of California | Implantable Cardioverter DefibrillatorsPayerPolicy · BSCA-Implantable-Cardioverter-Defibrillators | Criteria changed |
|---|
| May 17, 2026 | Blue Shield of California | Implantable Bone-Conduction and Bone-Anchored Hearing AidsPayerPolicy · BSCA-Implantable-Bone-Conduction-Bone-Anchored-Hearing-Aids | Criteria changed |
|---|
| May 17, 2026 | Blue Shield of California | Immune Cell Function AssayPayerPolicy · BSCA-Immune-Cell-Function-Assay | Criteria changed |
|---|
| May 17, 2026 | Blue Shield of California | Immediate and Delayed Lymphatic Reconstruction SurgeryPayerPolicy · BSCA-Immediate-Delayed-Lymphatic-Reconstruction-Surgery | Criteria changed |
|---|
| May 17, 2026 | Blue Shield of California | Image-Guided Minimally Invasive Decompression for Spinal StenosisPayerPolicy · BSCA-Image-Guided-Minimally-Invasive-Decompression-Spinal-Stenosis | Criteria changed |
|---|
| May 17, 2026 | Blue Shield of California | Identification of Microorganisms Using Nucleic Acid ProbesPayerPolicy · BSCA-Identification-Microorganisms-Using-Nucleic-Acid-Probes | Criteria changed |
|---|
| May 17, 2026 | Blue Shield of California | Hysterectomy Surgery for Benign ConditionsPayerPolicy · BSCA-Hysterectomy-Surgery-Benign-Conditions | Criteria changed |
|---|
| May 17, 2026 | Blue Shield of California | Hyperthermic Intraperitoneal Chemotherapy for Select Intra-Abdominal and Pelvic MalignanciesPayerPolicy · BSCA-Hyperthermic-Intraperitoneal-Chemo-Intra-Abdominal-Pelvic-Malignancies | Criteria changed |
|---|
| May 17, 2026 | Blue Shield of California | Hyperbaric Oxygen TherapyPayerPolicy · BSCA-Hyperbaric-Oxygen-Therapy | Criteria changed |
|---|
| May 17, 2026 | Blue Shield of California | Homocysteine Testing in the Screening, Diagnosis, and Management of Cardiovascular Disease and Venous Thromboembolic DiseasePayerPolicy · BSCA-Homocysteine-Test-Screening-DX-Cardiovascular-Dis-Venous-Thromboembolic | Criteria changed |
|---|
| May 17, 2026 | Blue Shield of California | Home Non-Invasive Positive Airway Pressure Devices for the Treatment of Respiratory Insufficiency and FailurePayerPolicy · BSCA-Home-Non-Invasive-Pos-Airway-Pressure-TX-Respiratory-Insufficiency | Criteria changed |
|---|
| May 17, 2026 | Blue Shield of California | Home Cardiorespiratory MonitoringPayerPolicy · BSCA-Home-Cardiorespiratory-Monitoring | Criteria changed |
|---|
| May 17, 2026 | Blue Shield of California | Hippotherapy (Equine/Horse therapy)PayerPolicy · BSCA-Hippotherapy-Equine-Horse-Therapy | Criteria changed |
|---|
| May 17, 2026 | Blue Shield of California | Hip ResurfacingPayerPolicy · BSCA-Hip-Resurfacing | Criteria changed |
|---|
| May 17, 2026 | Blue Shield of California | Hip Arthroplasty for AdultsPayerPolicy · BSCA-Hip-Arthroplasty-Adults | Criteria changed |
|---|
| May 17, 2026 | Blue Shield of California | High Intensity Laser Therapy for Chronic Musculoskeletal Pain Conditions and Bell's PalsyPayerPolicy · BSCA-HILT-Musculoskeletal-Pain-Bells-Palsy | Criteria changed |
|---|
| May 17, 2026 | Blue Shield of California | Hematopoietic Cell Transplantation in the Treatment of Germ Cell TumorsPayerPolicy · BSCA-HCT-Treatment-Germ-Cell-Tumors | Criteria changed |
|---|
| May 17, 2026 | Blue Shield of California | Hematopoietic Cell Transplantation for Solid Tumors of ChildhoodPayerPolicy · BSCA-HCT-Solid-Tumors-Childhood | Criteria changed |
|---|
| May 17, 2026 | Blue Shield of California | Hematopoietic Cell Transplantation for Primary AmyloidosisPayerPolicy · BSCA-HCT-Primary-Amyloidosis | Criteria changed |
|---|
| May 17, 2026 | Blue Shield of California | Hematopoietic Cell Transplantation for Plasma Cell Dyscrasias, Including Multiple Myeloma and POEMS SyndromePayerPolicy · BSCA-HCT-Plasma-Cell-Dyscrasias-Including-Multiple-Myeloma-POEMS-Syndrome | Criteria changed |
|---|
| May 17, 2026 | Blue Shield of California | Hematopoietic Cell Transplantation for Non-Hodgkin LymphomasPayerPolicy · BSCA-HCT-Non-Hodgkin-Lymphomas | Criteria changed |
|---|
| May 17, 2026 | Blue Shield of California | Hematopoietic Cell Transplantation for Miscellaneous Solid Tumors in AdultsPayerPolicy · BSCA-HCT-Miscellaneous-Solid-Tumors-Adults | Criteria changed |
|---|
| May 17, 2026 | Blue Shield of California | Hematopoietic Cell Transplantation for Hodgkin LymphomaPayerPolicy · BSCA-HCT-Hodgkin-Lymphoma | Criteria changed |
|---|
| May 17, 2026 | Blue Shield of California | Hematopoietic Cell Transplantation for Epithelial Ovarian CancerPayerPolicy · BSCA-HCT-Epithelial-Ovarian-Cancer | Criteria changed |
|---|
| May 17, 2026 | Blue Shield of California | Hematopoietic Cell Transplantation for Chronic Myeloid LeukemiaPayerPolicy · BSCA-HCT-Chronic-Myeloid-Leukemia | Criteria changed |
|---|
| May 17, 2026 | Blue Shield of California | Hematopoietic Cell Transplantation for Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaPayerPolicy · BSCA-HCT-Chronic-Lymphocytic-Leukemia-Small-Lymphocytic-Lymphoma | Criteria changed |
|---|
| May 17, 2026 | Blue Shield of California | Hematopoietic Cell Transplantation for Autoimmune DiseasesPayerPolicy · BSCA-HCT-Autoimmune-Diseases | Criteria changed |
|---|
| May 17, 2026 | Blue Shield of California | Hematopoietic Cell Transplantation for Acute Myeloid LeukemiaPayerPolicy · BSCA-HCT-Acute-Myeloid-Leukemia | Criteria changed |
|---|
| May 17, 2026 | Blue Shield of California | Hematopoietic Cell Transplantation for Acute Lymphoblastic LeukemiaPayerPolicy · BSCA-HCT-Acute-Lymphoblastic-Leukemia | Criteria changed |
|---|
| May 17, 2026 | Blue Shield of California | Heart/Lung TransplantPayerPolicy · BSCA-Heart-Lung-Transplant | Criteria changed |
|---|
| May 17, 2026 | Blue Shield of California | Handheld Radiofrequency Spectroscopy for Intraoperative Assessment of Surgical Margins During Breast-Conserving SurgeryPayerPolicy · BSCA-Handheld-Radiofrequency-Spectroscopy-Breast-Conserving-Surgery | Criteria changed |
|---|
| May 17, 2026 | Blue Shield of California | Germline Genetic Testing for Hereditary Breast/Ovarian Cancer Syndrome and Other High-Risk Cancers (BRCA1, BRCA2, PALB2)PayerPolicy · BSCA-Germline-Genetic-Test-Breast-Ovarian-Cancer-BRCA1-BRCA2-PALB2 | Criteria changed |
|---|
| May 17, 2026 | Blue Shield of California | Genetic Testing for the Diagnosis of Inherited Peripheral NeuropathiesPayerPolicy · BSCA-Genetic-Testing-Dx-Inherited-Peripheral-Neuropathies | Criteria changed |
|---|
| May 17, 2026 | Blue Shield of California | Genetic Testing for Statin-Induced MyopathyPayerPolicy · BSCA-Genetic-Test-Statin-Induced-Myopathy | Criteria changed |
|---|
| May 17, 2026 | Blue Shield of California | Genetic Testing for Predisposition to Inherited Hypertrophic CardiomyopathyPayerPolicy · BSCA-Genetic-Testing-Predispo-Inherited-Hypertrophic-Cardiomyopathy | Criteria changed |
|---|
| May 17, 2026 | Blue Shield of California | Genetic Testing for Mitochondrial DisordersPayerPolicy · BSCA-Genetic-Testing-Mitochondrial-Disorders | Criteria changed |
|---|
| May 17, 2026 | Blue Shield of California | Genetic Testing for Marfan Syndrome, Thoracic Aortic Aneurysms and Dissections, and Related DisordersPayerPolicy · BSCA-Genetic-Test-Marfan-Syndrome-Thoracic-Aneurysms-Dissections | Criteria changed |
|---|
| May 17, 2026 | Blue Shield of California | Genetic Testing for Macular DegenerationPayerPolicy · BSCA-Genetic-Testing-Macular-Degeneration | Criteria changed |
|---|
| May 17, 2026 | Blue Shield of California | Genetic Testing for Lynch Syndrome and Other Inherited Colon Cancer SyndromesPayerPolicy · BSCA-Genetic-Testing-Lynch-Syndrome-Inherited-Colon-Cancer-Syndromes | Criteria changed |
|---|
| May 17, 2026 | Blue Shield of California | Genetic Testing for Idiopathic Dilated CardiomyopathyPayerPolicy · BSCA-Genetic-Testing-Idiopathic-Dilated-Cardiomyopathy | Criteria changed |
|---|
| May 17, 2026 | Blue Shield of California | Genetic Testing for Heterozygous Familial HypercholesterolemiaPayerPolicy · BSCA-Genetic-Test-Heterozygous-Familial-Hypercholesterolemia | Criteria changed |
|---|
| May 17, 2026 | Blue Shield of California | Genetic Testing for Hereditary Hearing LossPayerPolicy · BSCA-Genetic-Test-Hereditary-Hearing-Loss | Criteria changed |
|---|
| May 17, 2026 | Blue Shield of California | Genetic Testing for FMR1 Variants (Including Fragile X Syndrome)PayerPolicy · BSCA-Genetic-Test-FMR1-Variants-Including-Fragile-X-Syndrome | Criteria changed |
|---|
| May 17, 2026 | Blue Shield of California | Genetic Testing for EpilepsyPayerPolicy · BSCA-Genetic-Testing-Epilepsy | Criteria changed |
|---|
| May 17, 2026 | Blue Shield of California | Genetic Testing for Duchenne and Becker Muscular DystrophyPayerPolicy · BSCA-Genetic-Test-Duchenne-Becker-Muscular-Dystrophy | Criteria changed |
|---|
| May 17, 2026 | Blue Shield of California | Genetic Testing for Diagnosis and Management of Mental Health ConditionsPayerPolicy · BSCA-Genetic-Testing-Dx-Management-Mental-Health-Conditions | Criteria changed |
|---|
| May 17, 2026 | Blue Shield of California | Genetic Testing for Developmental Delay/Intellectual Disability, Autism Spectrum Disorder, and Congenital AnomaliesPayerPolicy · BSCA-Genetic-Testing-Dev-Delay-Autism-Spectrum-Congenital-Anomalies | Criteria changed |
|---|
| May 17, 2026 | Blue Shield of California | Genetic Testing for Cardiac Ion ChannelopathiesPayerPolicy · BSCA-Genetic-Testing-Cardiac-Ion-Channelopathies | Criteria changed |
|---|
| May 17, 2026 | Blue Shield of California | Genetic Testing for Alzheimer DiseasePayerPolicy · BSCA-Genetic-Testing-Alzheimer-Disease | Criteria changed |
|---|
| May 17, 2026 | Blue Shield of California | Genetic Cancer Susceptibility Panels Using Next-Generation SequencingPayerPolicy · BSCA-Genetic-Cancer-Susceptibility-Panels-Using-Next-Gen-Sequencing | Criteria changed |
|---|